LON:SCLP Scancell (SCLP) Share Price, News & Analysis GBX 84 +2.00 (+2.44%) As of 11:57 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider TradesNews and Trends About Scancell Stock (LON:SCLP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Scancell alerts:Sign Up Key Stats Today's Range 80.30▼ 8450-Day Range 80▼ 101.6552-Week Range 79▼ 295Volume25,570 shsAverage Volume264,039 shsMarket Capitalization£113.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Scancell (LSE:SCLP) is a clinical stage company leveraging two proprietary platforms, Immunobody® and Moditope®, to develop targeted off-the-shelf, patient-accessible active immunotherapies for a cancer-free future. The lead product iSCIB1+ is an Immunobody® DNA active immunotherapy that has demonstrated monotherapy activity in adjuvant melanoma. When combined with checkpoint therapies it showed additional clinical benefit over the checkpoints (CPI) alone in the ongoing Phase 2 SCOPE trial in advanced melanoma. The precise patient population that iSCIB1+ brings benefit to, in combination with CPIs, has been identified, enabling precision-biomarker led registrational development. The lead Moditope® peptide active immunotherapy, Modi-1, is being investigated in a Phase 2 study in a broad range of solid tumours and also has shown encouraging interim clinical data. Scancell’s wholly-owned subsidiary, Glymab Therapeutics Ltd., has been established with the intention to develop an exciting early-stage pipeline of high affinity GlyMab® antibodies targeting tumour specific glycans, two of which already have been licensed and are being developed by Genmab A/S. Read More Receive SCLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SCLP Stock News HeadlinesScancell clears share consolidation as it readies AIM trading and deal pushOctober 21, 2026 | theglobeandmail.comIssue of Equity, Director Dealing & Voting RightsOctober 15, 2026 | markets.ft.comEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 16 at 1:00 AM | Behind the Markets (Ad)Scancell Advances Melanoma Phase 3 Plans and Secures Funding for Proposed Nasdaq ListingOctober 9, 2026 | uk.finance.yahoo.comScancell FY26 Loss Widens; ISCIB1+ Phase 2 SCOPE Data Due In 2027October 9, 2026 | rttnews.comScancell, Eco Buildings, ATOME, Caledonia Mining, Oxford Metrics - Small Cap SnapshotOctober 9, 2026 | uk.finance.yahoo.comMARKETS LIVE: Sage jumps 5% as software rebound keeps FTSE higherOctober 9, 2026 | ca.finance.yahoo.comScancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trialOctober 9, 2026 | finance.yahoo.comSee More Headlines SCLP Stock Analysis - Frequently Asked Questions How have SCLP shares performed this year? Scancell's stock was trading at GBX 101.20 at the start of the year. Since then, SCLP stock has decreased by 17.0% and is now trading at GBX 84. How were Scancell's earnings last quarter? Scancell Holdings plc (LON:SCLP) released its quarterly earnings data on Friday, October, 9th. The company reported GBX (17.30) EPS for the quarter. Scancell had a positive trailing twelve-month return on equity of 128.87% and a negative net margin of 116.98%. When did Scancell's stock split? Shares of Scancell reverse split before market open on Wednesday, October 21st 2026.The 1-10 reverse split was announced on Wednesday, October 21st 2026. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 21st 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Scancell? Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Scancell own? Based on aggregate information from My MarketBeat watchlists, some other companies that Scancell investors own include Petropavlovsk (POG), Lloyds Banking Group (LLOY), Genel Energy (GENL), Gulf Keystone Petroleum (GKP), KAZ Minerals (KAZ), AstraZeneca (AZN) and EKF Diagnostics (EKF). Company Calendar Last Earnings10/09/2026Today11/16/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:SCLP CIKN/A Webwww.scancell.co.uk Phone+44-115-8231863FaxN/AEmployees51Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (17.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£6.75 million Net Margins-116.98% Pretax MarginN/A Return on Equity128.87% Return on Assets-45.28% Debt Debt-to-Equity Ratio-88.01 Current Ratio0.28 Quick Ratio13.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 10.69 per share Price / Cash Flow7.86 Book ValueGBX (0.39) per share Price / Book-215.50Miscellaneous Outstanding Shares135,668,000Free FloatN/AMarket Cap£113.96 million OptionableNot Optionable Beta0.69 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (LON:SCLP) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredThis Could Be the Biggest Monetary Shift in 50 YearsThe U.S. government still values its gold reserves at $42 an ounce, a price set by Congress in 1973. Gold trad...Patriot Gold Group | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredGlobal Industrial Powerhouse Taps Nasdaq Drone MicrocapA Nasdaq-listed drone company just signed an exclusive agreement with Prime Strategic Holdings, part of billio...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scancell Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Scancell With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.